(NYSE:INSP), MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial […]
(NASDAQ:FRSH), SAN MATEO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Freshworks (NASDAQ: FRSH), today announced Kady Srinivasan has joined as its Chief Marketing Officer, bringing over 15 years of leadership experience driving large-scale marketing transformations at high-growth SaaS companies. Srinivasan will lead Freshworks' global marketing strategy to amplify the company's mission to deliver exceptional customer
Tune Clinical Aesthetics Introduces True Zero(TM) Laser Hair Removal in Chennai GlobeNewswire January 07, 2026 Chennai, India, Jan. 07, 2026 (GLOBE NEWSWIRE) — There is a certain quiet fatigue that comes with hair removal. The heat. The irritation. The endless cycle of waxing appointments, razor bumps, and skin that never quite feels settled. True Zero(TM)
(NasdaqGM:TARA), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 3:45 pm PT in San Francisco. A
Comscore's Cross-Platform Content Measurement to Service ESPN, Strengthening Audience Insights and Better Illuminating the Value of Its Fanbase (and Programming) Unified content measurement gives ESPN a clearer view of how fans engage across linear, streaming, digital, and social — revealing its total audience reach and programming impact GlobeNewswire January 07, 2026 NEW YORK, Jan. 07,
CAMBRIDGE, United Kingdom and NEW YORK, January 7, 2026 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (“DDR”) in cancer, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco from January 12 to
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange GlobeNewswire January 07, 2026 The listing on one of the world's largest global cryptocurrency exchanges expands market access and secondary liquidity for Enlivex's primary digital treasury asset Nes-Ziona, Israel, Jan. 07, 2026 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV,
(NASDAQ:EVAX), COPENHAGEN, Denmark, January 7, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines, will present at the Biotech Showcase conference taking place from January 12-14, 2026, in San Francisco, California. CEO Helen Tayton-Martin will present Evaxion's 2026 company milestones and provide a company update on January
Rezolve Ai to Take Center Stage at NRF 2026 as Agentic Commerce Emerges as Retail's Next Growth Engine Live Demonstrations with Microsoft to Highlight Enterprise Adoption [as AI Agents Drive Revenue at Scale] GlobeNewswire January 07, 2026 LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in Agentic Commerce and AI-powered
(NASDAQ:SNSE), PARIS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with autoimmune diseases and cancer, today announced the appointment of John Celebi, M.B.A., as chief executive officer. Mr. Celebi is a seasoned biotechnology executive